A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism

Yingjia Yao(Universidad del Noreste), Fei Teng(Tongji University), Zhisong Chen(Nanjing Normal University), Yunhan Zhang(Northeastern University), Zexu Li(Universidad del Noreste), Wei Li(Children's National), Zihan Li(Universidad del Noreste), Xiaofeng Wang(Virginia Tech), Wenjie Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaolong Cheng(The University of Texas at San Antonio Health Science Center), Zezhong Feng(Northeastern University), Hua‐Jun Wu(Chinese Academy of Sciences), Jinfu Sun(Northeastern University), Li Yu(Northeastern University)
bioRxiv (Cold Spring Harbor Laboratory)
June 5, 2023
Cited by 1


Related Papers